Mu opioid receptor expression is increased in inflammatory bowel diseases: Implications for homeostatic intestinal inflammation

Gut

Volumn 55, Issue 6, 2006, Pages 815-823

  Philippe, D ^a,b,c   Chakass, D ^a,b,c   Thuru, X ^a,b,c   Zerbib, P ^a   Tsicopoulos, A ^d   Geboes, K ^e   Bulois, P ^a,b,c   Breisse, M ^a,b,c   Vorng, H ^d   Gay, J ^a,b,c   Colombel, J F ^a,b,c   Desreumaux, P ^a,b,c   Chamaillard, M ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ANTIBIOTIC AGENT; CYCLOSPORIN A; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; MU OPIATE RECEPTOR; OPIATE; PRIMER DNA; STEROID; TUMOR NECROSIS FACTOR ALPHA; TYROSYL DEXTRO ARGINYLPHENYLALANYLLYSINAMIDE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; ENTERITIS; FEMALE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA; ULCERATIVE COLITIS;

ADULT; ANALGESICS, OPIOID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; CYTOKINES; FEMALE; HOMEOSTASIS; HUMANS; ILEUM; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646809695     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.080887     Document Type: Article

References (43)

1. Kieffer BL. Recent advances In molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol 1995;15:615-35.
2. Mansour A, Fox CA, Burke S, et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 1994;350:412-38.
3. Mansour A, Fox CA, Akil H, et al. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995;18:22-9.
4. Mansour A, Fox CA, Burke S, et al. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Cnem Neuroanat 1995;8:283-305.
5. Coggeshall RE, Zhou S, Carlton SM. Opioid receptors on peripheral sensory axons. Brain Res 1997;764:126-32.
6. Sternini C. Receptors and transmission in the brain-gut axis: potential for novel therapies. III. Mu-opioid receptors in the enteric nervous system. Am J Physiol Gastrointest Liver Physiol 2001;281:G8-15.
7. Elvenes J, Andjelkov N, Figenschau Y, et al. Expression of functional mu-opioid receptors in human osteoarthritic cartilage and chondrocytes. Biochem Biophys Res Commun 2003;311:202-7.
8. Kieffer BL, Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 2002;66:285-306.
9. Tegeder I, Geisslinger G. Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol Rev 2004;56:351-69
10. Law PY, Loh HH, Wei LN. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 2004;47(suppl 1):300-11.
11. Pol O, Puig MM. Expression of opioid receptors during peripheral inflammation. Curr Top Med Chem 2004;4:51-61.
12. Wei LN, Loh HH. Regulation of opioid receptor expression. Curr Opin Pharmacol 2002;2:69-75.
13. Roy S, Barke RA, Loh HH. MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 1998;61:190-4.
14. Inui Y, Azuma Y, Ohura K. Differential alteration of functions of rat peritoneal macrophages responsive to endogenous opioid peptide endomorpnin-1. Int Immunopharmacol 2002;2:1133-42.
15. Gomez-Flores R, Weber RJ. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology 2000;48:145-56.
16. Philippe D, Dubuquoy L, Groux H, et al. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 2003;111:1329-38.
17. Kraus J, Borner C, Giannini E, et al. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 2001;276:43901-8.
18. Valle L, Pol O, Puig MM. Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice. J Pharmacol Exp Ther 2001;296:378-87.
19. Turnberg LA. Antisecretory activity of opiates in vitro and in vivo in man. Scand J Gastroenterol Suppl 1983;84:79-83.
20. Boyd CA. Opiates and intestinal secretion. Lancet 1976;2:1085.
21. Gray AC, White PJ, Coupar IM. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum. Br J Pharmacol 2005;144:687-94.
22. Liu BH, Mo P, Zhang SB. Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon. World J Gastroenterol 2004;10:1672-4.
23. Panerai AE, Sacerdote P. Beta-endorphin in the immune system: a role at last? Immunol Today 1997;18:317-19.
24. O'Connor TM, O'Connell J, O'Brien DI, et al. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-80.
25. Nguyen XD, Eichler H, Dugrillon A, et al. Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods 2003;275:57-68.
26. Stanciu LA, Shute J, Holgate ST, et al. Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS). J Immunol Methods 1996;189:107-15.
27. Borruel N, Carol M, Casellas F, et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002;51:659-64.
28. Satoh M, Minami M. Molecular pharmacology of the opioid receptors. Pharmacol Ther 1995;68:343-64.
29. Townsend DT, Portoghese PS, Brown DR. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine. J Pharmacol Exp Ther 2004;308:385-93.
30. Lang ME, Davison JS, Bates SL, et al. Opioid receptors on guinea-pig intestinal crypt epithelial cells. J Physiol 1996;497:161-74.
31. Quito FL, Seybold VS, Brown DR. Opiate binding sites in mucosa of pig small intestine. Life Sci 1991;49:L219-22.
32. Zubieta JK, Smith YR, Bueller JA, et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001;293:311-15.
33. Hassan AH, Ableitner A, Stein C, et al. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 1993;55:185-95.
34. Jeanjean AP, Moussaoui SM, Maloteaux JM, et al. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 1995;68:151-7.
35. Mousa SA, Zhang Q, Sitte N, et al. Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 2001;115:71-8.
36. Puig MM, Pol O. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice. J Pharmacol Exp Ther 1998;287:1068-75.
37. Koch TR, Carney JA, Go VL. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987;32:369-76.
38. Wiedermann CJ, Sacerdote P, Propst A, et al. Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease. Brain Behav Immun 1994;8:261-9.
39. Borner C, Hollt V, Kraus J. Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene. Mol Pharmacol 2002;61:800-5.
40. Bidlack JM. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol 2000;7:719-23.
41. Sharp BM. Opioid receptor expression and function. J Neuroimmunol 2004;147:3-5.
42. Chuang TK, Killam KF Jr, Chuang LF, et al. Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun 1995;216:922-30.
43. Makarenkova VP, Esche C, Kost NV, et al. Identification of delta- and mu-type opioid receptors on human and murine dendritic cells. J Neuroimmunol 2001;117:68-77.